Interruption of insulin delivery may cause elevated blood glucose (hyperglycemia), which, if left untreated, can result in diabetic ketoacidosis.
Manufacturing problem causes the affected thermometers to display temperatures that are lower than actual body temperatures, which may cause the user or caregiver of the user to delay or forego seeking appropriate care.
The use of affected product may cause serious adverse health consequences, including death.
Consumption of this product may result in vitamin D toxicity, which may be severe and may lead to life-threatening outcomes if left untreated.
Serious adverse events reported, including pulmonary embolism, pulmonary infarction, myocardial embolism, myocardial infarction, embolic stroke, tissue necrosis, and death.
L'EMA ha ora completato la sua revisione dell'evidenza derivante dalle
segnalazioni della sindrome dolorosa regionale complessa (CRPS) e della
sindrome da tachicardia posturale ortostatica (POTS).
L'Agenzia Italiana del Farmaco rende disponibili importanti
informazioni di sicurezza riguardanti nuove misure di minimizzazione del rischio di leucoencefalopatia multifocale progressiva (PML) correlato all’uso di Tecfidera nel trattamento della sclerosi multipla.
Labels of all iodinated contrast media (ICM) products will include information about these cases. No changes to current prescribing, administration, or monitoring practices are recommended.
Background
NICE – the National Institute for Clinical Excellence – was established in 1999 by the UK’s Department of Health as an independent body free from political (or other) vested interests. Its remit was to provide advice (“guidance”) to enable health professionals, working in the National Health Service (NHS), to achieve the highest attainable standards of care for their patients.
NICE’s original remit was limited to undertaking “technology appraisals” and to develop “clinical guidelines”. Over the subsequent 15 years, however, its role has been expanded to include other forms of guidance (Table 1). The Institute’s core business, however, remains the production and publication of technology appraisals and clinical guidelines.
Technology appraisals
These provide advice on the clinical and cost effectiveness of predominantly pharmaceutical products. Although, in the early years, it gave advice on the use of devices and diagnostics these have now been subsumed into other guidance programmes (Table 1).
If failure occurs, and the operator does not intervene, the patient may not receive enough oxygen and could suffer serious adverse health consequences, including injury or death.
80.211.154.110
